ClearNote Health
Develops noninvasive blood-based early detection tests for pancreatic and ovarian cancers
$52MSeries D
Role not disclosedLoading investors…
Activity from announced rounds
Develops noninvasive blood-based early detection tests for pancreatic and ovarian cancers